LitCovid-sample-Enju  

PMC:7205724 / 180-466 JSONTXT 11 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T24 1-2 IN denotes •
T25 4-8 NNP denotes IVIG
T26 8-9 -COMMA- denotes ,
T27 10-18 VBN denotes combined
T28 19-23 IN denotes with
T29 24-37 NN denotes moderate-dose
T30 38-40 IN denotes of
T31 41-56 NNS denotes corticosteroids
T32 56-57 -COMMA- denotes ,
T33 58-63 MD denotes might
T34 64-71 VB denotes improve
T35 72-79 NN denotes patient
T36 80-88 NNS denotes outcomes
T37 90-91 PDT denotes •
T38 93-96 DT denotes The
T39 97-100 NN denotes use
T40 101-103 IN denotes of
T41 104-119 NNS denotes corticosteroids
T42 120-125 MD denotes might
T43 126-136 VB denotes accelerate
T44 137-145 NN denotes recovery
T45 146-150 IN denotes from
T46 151-159 NN denotes COVID-19
T47 161-162 PDT denotes •
T48 164-166 DT denotes No
T49 167-177 VBN denotes controlled
T50 178-186 JJ denotes clinical
T51 187-193 NNS denotes trials
T52 194-199 VBP denotes exist
T53 200-202 IN denotes on
T54 203-206 DT denotes the
T55 207-210 NN denotes use
T56 211-213 IN denotes of
T57 214-229 NNS denotes corticosteroids
T58 230-233 IN denotes for
T59 234-242 NN denotes COVID-19
T60 244-245 LS denotes •
T61 247-250 NN denotes IL6
T62 251-261 VBZ denotes correlates
T63 262-266 IN denotes with
T64 267-275 NN denotes severity
T65 275-276 -COMMA- denotes ,
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R59 T64 T65 arg1Of severity,","